share_log

HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $13 Price Target

HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $13 Price Target

HC Wainwright & Co.重申買入Aurinia Pharmicals,維持13美元的目標股價
Moomoo 24/7 ·  03/01 14:09

HC Wainwright & Co. analyst Ed Arce reiterates Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and maintains $13 price target.

HC Wainwright & Co. 分析師埃德·阿爾塞重申奧里尼亞製藥公司(納斯達克股票代碼:AUPH)的買入並維持13美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論